Evaluation of Awareness and Knowledge of Pharmacovigilance amongst Final Year Students of Rivers State College of Health Science and Management Technology, Nigeria
Abstract
Adverse drug reactions (ADRs) till date are still considered as one of the main problems of drug therapy. Pharmacovigilance is the monitoring of drug safety by means of spontaneous adverse-effect reporting systems, case control and cohort studies.
This study evaluated the levels of awareness and knowledge of pharmacovigilance (i.e., ADR reporting) amongst final year students of Rivers State College of Health Science and Technology, Port Harcourt, Nigeria. It was a cross sectional awareness and knowledge survey amongst 200 students from the eight Schools of the institution. Specially adapted and structured questionnaires were administered to the students to obtain information on their levels of awareness and knowledge on reporting of ADRs. Simple descriptive statistics was used to analyze the data that were obtained. The result showed that over 72% of the students from each of the Schools had good knowledge of ADR, about 62% were aware of ADR reporting system, while less than 50% had knowledge of the process of reporting ADRs.
Final year students of College of Health Science and Technology, Port Harcourt have good knowledge of ADR. However, their awareness of the reporting system and particularly the process of reporting (pharmacovigilance) is poor and needs improvement.
Keywords: Awareness, adverse drug reaction, pharmacovigilance
Downloads
References
2. Calis K A and Young L R, Clinical analysis of adverse drug reactions: A primer for clinicians. Hosp Pharm. 2004; 39:697-712. https://doi.org/10.1177/001857870403900712
3. Fincham J E, An overview of drug reactions. Am Pharm; 1991; NS31:435 - 41. https://doi.org/10.1016/S0160-3450(16)33754-0
4. Edwards I R and Aronson J K. Adverse drug reactions: definition, diagnosis and management. Lancet; 2000; 356:1255-9 https://doi.org/10.1016/S0140-6736(00)02799-9
5. Gruchalla R S. Clinical assessment of drug induced diseases. Lancet; 2000; 356:1505-51. https://doi.org/10.1016/S0140-6736(00)02885-3
6. World Health Organization. WHO policy perspectives in medicines. 2004.
7. Aziz Z,Tan Ching Siang Bpharm,Nurul Suhaida Badarudin BPharm. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharmacoepidemiology and Drug safety. 2006; 16(2):223 - 228. https://doi.org/10.1002/pds.1313
8. Pimpalkhute S; Jaiswal K; Sontakke S; Bajait C; Gaikwad A. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital. Indian Journal of Medical Sciences; Mumbai 2012; 66(3/4):55-61. https://doi.org/10.4103/0019-5359.110902
9. Gupta P; Udupa, A. Adverse Drug Reaction Reporting and Pharmacovigilance: Knowledge, Attitudes and Perceptions amongst Resident Doctors. J Pharm Sc Res 2011; 3(2):1064-1069.
10. Hazell L, Shakir SAW. Under-Reporting of Adverse Drug Reactions: A Systematic Review. Drug Safety. 2006; 29:385-396 https://doi.org/10.2165/00002018-200629050-00003
11. Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. British Journal of Clinical Pharmacology. 2007; 63 (2):148 - 156. https://doi.org/10.1111/j.1365-2125.2006.02746.x
12. Robertson J, Newby DA, Low awareness of adverse drug reaction reporting systems: a consumer survey. Med J Aust 2013; 199(10):684-686. https://doi.org/10.5694/mja13.10069
13. Shamim S, Sharib SM, Malhi SM, Muntaha S, Raza H, Farooq AS, Hussain M. Adverse drug reactions (ADRS) reporting: awareness and reasons of under-reporting among health care professionals, a challenge for pharmacists. Springerplus 2016; 5(1):1778. https://doi.org/10.1186/s40064-016-3337-4
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.